Featured Research

from universities, journals, and other organizations

New ammunition in fight against type 2 diabetes

Date:
April 7, 2014
Source:
Monash University
Summary:
Gastric banding can play a vital role in the treatment of type 2 diabetes in people who are overweight and not obese, according to new research. "This is the first randomized controlled trial demonstrating that treatment of type 2 diabetes in overweight people by substantial weight loss is safe and hugely beneficial," the lead author said. "As there are no alternative options that can achieve such a result, this study indicates a potentially attractive path for the overweight person with diabetes and for those providing the care."

Gastric banding can play a vital role in the treatment of type 2 diabetes in people who are overweight and not obese, according to new research.

Related Articles


The Monash University study, led by Emeritus Professor Paul O'Brien and Dr John Wentworth from the Centre for Obesity Research and Education (CORE), has determined that weight loss surgery (gastric banding) for overweight people with diabetes had a profound impact on the illness.

The research has been released today in the medical journal The Lancet Diabetes and Endocrinology.

"This is the first randomized controlled trial demonstrating that treatment of type 2 diabetes in overweight people by substantial weight loss is safe and hugely beneficial," Professor O'Brien said. "As there are no alternative options that can achieve such a result, this study indicates a potentially attractive path for the overweight person with diabetes and for those providing the care."

The study looked at people who suffered diabetes and were overweight, but not obese. The connection between excessive body weight and diabetes is well known, but while the benefits of weight loss for obese people suffering type 2 diabetes have been well document, it has not been clear if those who were overweight would enjoy the same benefits.

The study enrolled 50 people with diabetes who were overweight, but not obese, with a body mass index between 25 and 30.

"We provided a comprehensive program of multidisciplinary care to all of the participants, but randomly allocated half of them to receive an additional treatment of adjustable gastric banding," Professor O'Brien explained.

"The surgery was conducted as an outpatient procedure with no significant adverse effects. We were pleased to see was that after two years into the trial, more than half of the banded group were in remission of their diabetes while only eight per cent of the non banded group were in remission."

The results showed a strong relationship between the amount of weight loss and remission of diabetes, clearly showing that successful ways of reducing weight such as gastric banding should have a high priority in the treatment of diabetes.

With over a million Australians suffering from type 2 diabetes, and an additional 270 people per day being diagnosed with the illness, the need to manage diabetes has never been greater.


Story Source:

The above story is based on materials provided by Monash University. Note: Materials may be edited for content and length.


Journal Reference:

  1. John M Wentworth, Julie Playfair, Cheryl Laurie, Matthew E Ritchie, Wendy A Brown, Paul Burton, Jonathan E Shaw, Paul E O'Brien. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. The Lancet Diabetes & Endocrinology, 2014; DOI: 10.1016/S2213-8587(14)70066-X

Cite This Page:

Monash University. "New ammunition in fight against type 2 diabetes." ScienceDaily. ScienceDaily, 7 April 2014. <www.sciencedaily.com/releases/2014/04/140407214906.htm>.
Monash University. (2014, April 7). New ammunition in fight against type 2 diabetes. ScienceDaily. Retrieved March 28, 2015 from www.sciencedaily.com/releases/2014/04/140407214906.htm
Monash University. "New ammunition in fight against type 2 diabetes." ScienceDaily. www.sciencedaily.com/releases/2014/04/140407214906.htm (accessed March 28, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, March 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins